About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT00502710

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

This 5 arm study will assess the efficacy, pharmacokinetics, safety and tolerability of a DPP-IV inhibitor compared to placebo in patients with type 2 diabetes. Patients will be randomized to receive ...

Lead sponsor: Hoffmann-La Roche•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Hoffmann-La Roche

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•adult patients, 18-75 years of age;
•type 2 diabetes diagnosed \>= 1 month before screening;
•drug-naive, or pretreated with maximum tolerated dose (MTD) of metformin;
•BMI 25-45kg/m2.

Exclusion Criteria

•type 1 diabetes;
•any anti-hyperglycemic medication other than metformin, or weight-lowering drug, during last 3 months.

Related studies

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

NCT06525259 · Diabetes Mellitus Type 2, Childhood-Onset

Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery

NCT05934409 · Diabetes Mellitus Type 2

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

Impact of Long Alimentary Limb or Long Biliary Limb Roux-en-Y Gastric Bypass on Type 2 Diabetes Remission in Severely Obese Patients.

NCT03821636 · Diabetes Mellitus Type 2 in Obese

Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial

NCT06957093 · Diabetes Mellitus Type 2 (T2DM), Artificial Intelligence (AI)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 5, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment289

Start dateJul 2007

Last updatedAug 5, 2016

Condition

Diabetes Mellitus Type 2

Locations shown

Hot Springs, Arkansas

Concord, California

Los Angeles, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 5, 2016Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions